PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Ansell Healthcare

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Ansell Extends Success of AMT Antimicrobial Technology for Surgical Gloves with Introduction in Europe - Global leader in healthcare protection and safety solutions lands CE Mark for GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology - Ansell.eu
Ansell Extends Success of AMT Antimicrobial Technology for Surgical Gloves with Introduction in Europe

 

NewswireToday - /newswire/ - Brussels, Belgium, 2011/11/01 - Global leader in healthcare protection and safety solutions lands CE Mark for GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology - Ansell.eu.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

One year after its introduction in Australia, Ansell today announced it is kicking off a European launch program of their new GAMMEX® Powder-Free glove with AMT Antimicrobial Technology

The GAMMEX® Powder-Free glove with AMT Antimicrobial Technology is the first surgical glove which incorporates a proprietary antimicrobial coating to provide an additional level of protection to surgical staff against viruses and bacteria, in the event of a breach during surgery.

Ever since its introduction last year in Australia, this unique Ansell innovation received overall industry acclaim and is being considered a significant technical breakthrough in terms of bringing about a change from passive protection to active protection.

The gloves, made of natural rubber latex, provide the same feel, sensitivity, flexibility and dexterity as conventional gloves when manipulating and handling instruments. The main difference is the active antimicrobial layer which contains chlorhexidine gluconate (CHG). This proprietary technology can provide ongoing antiviral and antibacterial protection against HIV, hepatitis C and infectious bacteria.

"Improving healthcare systems around the world and an increasing awareness by healthcare workers that gloves offer an effective protection against contamination from bacteria and viruses have been a key driver for the rapid expansion of the medical gloves industry", says Magnus Nicolin, CEO of Ansell Limited.

"This unique and proprietary AMT Antimicrobial Technology reduces surgical staff risks of exposure to blood-borne pathogens through a higher level of protection", he continues. "Just as the introduction of the first surgeon gloves significantly decreased surgical site infections, Ansell has great expectations that this glove will take patient protection to another level. We will now be focusing our research efforts on clinically quantifying the potential that this surgical glove innovation has on reducing the number of Hospital Acquired Infections (HAI's) and any costs associated", he concludes.

First launched in Australia and Europe, Ansell's AMT Antimicrobial Technology will progressively be rolled out in all Ansell markets.

* In clinical and laboratory tests, GAMMEX® Powder-Free with AMT killed at least 99% of invading HIV and HCV (hepatitis C) surrogate pathogens, the two main viruses that concern surgeons. In addition, clinical testing has shown that the gloves kill over 99.7% of eight common infectious bacteria (gram-positive, gram-negative and drug-resistant bacteria) and kill over 99.99% of staphylococcus aureus.

GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the skin is broken, cut or punctured. GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.

Australia Patent No. 703926 and New Zealand Patent No. 556353. AU and worldwide patents pending.

Ansell, ® and TM are trademarks owned by Ansell Limited or one of its affiliates. © 2011 Ansell Limited. All rights reserved.

Media contact
Mr Peter Brookes, Citadel PR (Australia)
P: + 61 0407 911 389

Investor relations team
Mr David Graham, General Manager Finance & Treasury
P: +61 3 9270 7215 / F: +61 3 9270 7300

Mr Rustom Jilla, Chief Financial Officer
P: + 1 732 345 5359 / F: + 1 732 219 5114

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Ansell Healthcare

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Ansell Extends Success of AMT Antimicrobial Technology for Surgical Gloves with Introduction in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Ansell Limited |
Publisher Contact: Wouter Piepers - Ansell.eu 
+32 2 528 74 00 info[.]ansell.eu
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Ansell Healthcare securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Ansell Healthcare / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)